MEDP Medpace Holdings, Inc.

BULLISH Impact: 5/10 COURT-RULING
Horizon days Filed Dec 4, 2025 Processed 2d 2h ago Court View Ruling on CourtListener
Court ruling (district)

Price Chart

Loading chart...

Executive Summary

Medpace, Inc. obtained a default judgment against Agenus Inc. and Garo H. Armen in a breach-of-contract and breach-of-fiduciary-duty lawsuit after the defendants failed to comply with discovery obligations and did not oppose the sanctions motion. The court struck defendants' answers and granted default judgment, with Medpace to file a proposed judgment by December 10, 2025. This removes litigation uncertainty for Medpace and positions it to recover damages, though the amount has not yet been determined.

Court Ruling Details

Ruling Date
Dec 4, 2025
Court
United States District Court, Southern District of New York
Court Level
District
Judge
Jesse M. Furman
Case Type
contract
Ruling Type
final judgment
Outcome
WIN — ruling favors this company
Will It Be Appealed?
Possible
Appeal Timeline
not_applicable
Precedent Risk
LOW

Actionable Insight

Monitor Medpace's proposed judgment filing (due Dec 10, 2025) for the damages amount, which will determine the financial impact. The default judgment removes litigation risk for Medpace, but the stock may already reflect this win given the pre-filing investigation window. Watch for any appeal by defendants or settlement before judgment entry.

Key Facts

  • Medpace sued Agenus Inc. and Garo H. Armen for breach of contract and breach of fiduciary duty.
  • Defendants engaged in 'wholesale noncompliance' with discovery obligations and failed to oppose the sanctions motion.
  • Court granted default judgment, striking defendants' answers, on December 4, 2025.
  • Medpace must file a proposed judgment by December 10, 2025; damages amount not yet specified in the opinion.
  • The ruling is a final judgment on liability, with damages to be determined.

Financial Impact

Damages not yet quantified; Medpace to file proposed judgment by December 10, 2025.

legal liabilityuncertainty resolution

Risk Factors

  • Damages awarded may be below market expectations if the proposed judgment is modest.
  • Defendants could appeal the default judgment, prolonging uncertainty.
  • Agenus Inc. (AGEN) may face financial strain, but this is a separate ticker concern.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
45% bullish (20 analysts)

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-24xutg8h-MEDP
3 reports for MEDP
Performance horizon
Filters
Rows
Reports for MEDP — sortable, filterable
Type Now
Apr 22, 2026
7w ago
8-K
MIXED ★ 6/10
$393.42 $421.87▲ +7.23%▲ +2.60%$465.73 (+18.38%)
Apr 1, 2026
9w ago
DEFA14A
NEUTRAL ★ 3/10
$498.34 $418.66▼ −15.99%▼ −25.87%$465.73 (−6.54%)
Dec 4, 2025
26w ago
Court Ruling
BULLISH ★ 5/10
$577.28 awaiting T+20awaiting T+20$465.73 (−19.32%)
Showing 3 of 3

US Market Status

Market Closed — Opens Thu (17h 12m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access